Integral Health Asset Management, LLC / CYTK
Integral Health Asset Management, LLC’s Cytokinetics Inc Position
Does Integral Health Asset Management, LLC own Cytokinetics Inc (CYTK)? Yes — 1.60M shares worth $105M (+5.04% of its 13F portfolio) as of Q1 2026, up from 1.40M shares the prior filed quarter.
Position Value
$105M
Q1 2026
Shares
1.60M
% of Portfolio
+5.04%
Quarters Held
25
currently held
Position History CYTK
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 1.60M | $105M | +5.04% |
| Q4 2025 | 1.40M | $89M | +4.42% |
| Q3 2025 | 1.40M | $77M | +5.21% |
| Q2 2025 | 1.00M | $33M | +3.02% |
| Q1 2025 | 1.10M | $44M | +4.70% |
| Q4 2024 | 1.00M | $47M | +4.01% |
| Q3 2024 | 750.0K | $40M | +4.46% |
| Q2 2024 | 1.00M | $54M | +5.15% |
| Q1 2024 | 450.0K | $32M | +2.93% |
| Q4 2023 | 200.0K | $17M | +2.27% |
| Q3 2023 | 800.0K | $24M | +3.26% |
| Q2 2023 | 650.0K | $21M | +2.63% |
| Q1 2023 | 600.0K | $21M | +4.25% |
| Q4 2022 | 400.0K | $18M | +3.85% |
| Q3 2022 | 350.0K | $17M | +3.29% |
| Q2 2022 | 525.0K | $21M | +4.24% |
| Q1 2022 | 470.0K | $17M | +4.50% |
| Q4 2021 | 325.0K | $15M | +4.10% |
| Q3 2021 | 325.0K | $12M | +3.34% |
| Q2 2021 | 700.0K | $14M | +3.81% |
| Q1 2021 | 700.0K | $16M | +4.65% |
| Q4 2020 | 525.0K | $11M | +3.25% |
| Q3 2020 | 200.0K | $4M | +1.32% |
| Q2 2020 | 340.0K | $8M | +2.40% |
| Q1 2020 | 320.0K | $4M | +1.66% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Integral Health Asset Management, LLC’s full portfolio or all institutional holders of CYTK.